Small Cell Neuroendocrine Carcinoma — Trials

Small Cell Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,165 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 396
Recruiting: 209
Ph III recruiting: 27
Growth YoY: +1%
Industry share: 42%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 1–50 of 179 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06478043	A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC	completed	Phase 2	60	Zhejiang Cancer HospitalOTHER	1	Aug 27, 2026	clinicaltrials
NCT04209595	PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers	completed	Phase 1 / Phase 2	10	National Cancer Institute (NCI)NIH	1	Aug 26, 2026	clinicaltrials